MolDX: Molecular Diagnostic Tests (MDT)
J15 · Effective Oct 1, 2015
22 active Medicare policies list 0533U, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J15 · Effective Jun 7, 2020
JE · Effective Aug 3, 2020
6 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 0533U |
|---|---|---|
| Evaluating the Utility of Genetic Panels | Jul 1, 2026 | Covered |
| Genetic Testing for Diagnosis and Management of Behavioral Health Conditions | Jul 1, 2026 | Covered |
| Policy | Effective | Status of 0533U |
|---|---|---|
| Pharmacogenetic Testing | Jun 14, 2026 | Covered |
JF · Effective Aug 3, 2020
JJ · Effective May 31, 2020
JM · Effective May 31, 2020
J5 · Effective Jun 14, 2020
J8 · Effective Jun 14, 2020
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
J5 · Effective Jul 1, 2026
J5 · Effective Jul 1, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
| Policy | Effective | Status of 0533U |
|---|
| Pharmacogenetic Panel Testing | Oct 1, 2026 | Covered |
|---|
| Policy | Effective | Status of 0533U |
|---|---|---|
| Pharmacogenetic Panel Testing | Oct 1, 2026 | Covered |
| Policy | Effective | Status of 0533U |
|---|---|---|
| Pharmacogenetic Panel Testing | Oct 1, 2026 | Covered |